Researchers Seek Common Ground On Regeneration

Ah, the privileged life of a salamander. Chop off a limb, and within days a new one grows in its place. In recent years, scientists have become increasingly interested in tracing the molecular origins of this seemingly magical ability. By harnessing the mechanisms involved in a number of animal models, researchers hope to one day grow a variety of new human tissues in place of the old or defective, thereby supplanting the need for less "natural" remedies such as bionic limbs or organ transplant

Written byEugene Russo
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Ah, the privileged life of a salamander. Chop off a limb, and within days a new one grows in its place. In recent years, scientists have become increasingly interested in tracing the molecular origins of this seemingly magical ability. By harnessing the mechanisms involved in a number of animal models, researchers hope to one day grow a variety of new human tissues in place of the old or defective, thereby supplanting the need for less "natural" remedies such as bionic limbs or organ transplantation. Unlike common wound healing, regeneration leaves a perfect replacement of the original tissue without scarring.

Driven by basic research advances in cell and developmental biology, immunology, and surface and polymer chemistry, regenerative biology generally involves either the transplantation of isolated adult, fetal, or stem cells, the implantation of bioartificial tissues into a biodegradable scaffold or matrix, or the induction of regeneration in situ. Despite progress in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies